The U.S. Secretary of Veterans Affairs on Tuesday cleared up a common misconception about the oft-cited “VA study” on the anti-malarial drug hydroxychloroquine, telling reporters that the VA did not conduct study, and furthermore, “on any given day, the VA uses 42,000 doses of the drug.”